These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. McEvoy JP. J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553 [Abstract] [Full Text] [Related]
3. Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients. Hitri A, Craft RB, Sethi R, Sinha D. Clin Neuropharmacol; 1987 Jun; 10(3):261-71. PubMed ID: 2900683 [Abstract] [Full Text] [Related]
13. Anticholinergic effects on memory: benztropine vs. amantadine. Van Putten T, Gelenberg AJ, Lavori PW, Falk WE, Marder SR, Spring B, Mohs RC, Brotman AW. Psychopharmacol Bull; 1987 Aug; 23(1):26-9. PubMed ID: 3602326 [No Abstract] [Full Text] [Related]
14. Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers. McEvoy JP, McCue M, Spring B, Mohs RC, Lavori PW, Farr RM. Am J Psychiatry; 1987 May; 144(5):573-7. PubMed ID: 3578566 [Abstract] [Full Text] [Related]
19. The need for continuous use of antiparkinsonian medication with chronic schizophrenic patients receiving long-term neuroleptic therapy. Manos N, Gkiouzepas J, Logothetis J. Am J Psychiatry; 1981 Feb; 138(2):184-8. PubMed ID: 6109453 [Abstract] [Full Text] [Related]